Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities
NCT01588496
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Homozygous Familial Hypercholesterolemia
Interventions
BIOLOGICAL:
Evolocumab
DRUG:
Placebo
Sponsor
Amgen